Sofosbuvir, a novel nucleotide analogue inhibitor used for the treatment of hepatitis C virus

The Journal of pharmacy and pharmacology

Volumn 66, Issue 12, 2014, Pages 1653-1666

  Summers, Bryant B ^a   Beavers, Joshua W F ^a   Klibanov, Olga M ^a  

^a WINGATE UNIVERSITY   (United States)

Author keywords

hepatitis C; NS5B polymerase inhibitor; sofosbuvir

Indexed keywords

ANTIVIRUS AGENT; NS-5 PROTEIN, HEPATITIS C VIRUS; SOFOSBUVIR; URIDINE PHOSPHATE; VIRUS PROTEIN;

ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL (TOPIC); DRUG COMBINATION; DRUG EFFECTS; ENZYMOLOGY; HEPACIVIRUS; HEPATITIS C; HUMAN; METABOLISM; TREATMENT OUTCOME; VIROLOGY;

ANTIVIRAL AGENTS; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C; HUMANS; TREATMENT OUTCOME; URIDINE MONOPHOSPHATE; VIRAL NONSTRUCTURAL PROTEINS;

EID: 85027956949     PISSN: None     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12294     Document Type: Review

References (0)